Search - tctmd.com

Displaying 181 - 200 of 1375

Sort: Relevancy | Date

News Daily News

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

Caitlin E. Cox

May 20, 2024

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Todd Neale

May 16, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

Caitlin E. Cox

May 08, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

News Daily News

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

L.A. McKeown

April 18, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Conference News ACC 2024

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Michael O'Riordan

April 15, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Shelley Wood

April 11, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News EHRA 2024

Study Bolsters AF’s Link to Brain Infarcts, Cognitive Impairment

Todd Neale

April 08, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Caitlin E. Cox

April 06, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

Advertisement

Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Atherosclerosis Progression May Share Traits With Tumor Growth

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Need a Statin for Primary Prevention? There’s an App for That

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Study Bolsters AF’s Link to Brain Infarcts, Cognitive Impairment

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content